Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of IMOVAX Polio in selected cities in China
2015-005185-34Phase 4
- Sponsor
- Sanofi
- Start
- Nov 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of inactivated poliovirus vaccine in poliomyelitis, sponsored by Sanofi. Primary endpoint: Safety profile within 28 days after each dose.
02
Drugs
inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2015-005185-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005185-34.